Email not displaying properly? View email in your browser
Vertical-Talk Healthcare   >  Cytiva
>  Nanotherapeutics
>  Multiple Myeloma
  July 2021   e-Newsletter Advertise | Editorial Calendar 
Abzena - Early Therapeutic Antibody Development
Latest e-Book
Articles
>  Meet scientist Daria Donati
Daria Donati, Head of Business Development Bioprocess, Cytiva
Before I went, I had preconceptions about what people can do. But I met doctors there who could run a diagnosis without modern tools...
>  Novel Claudin Targeted C-terminal Clostridium Perfringens Enterotoxin      Conjugated Anticancer Nanotherapeutics
Dr. Sushil Y. Raut Assistant Professor and Head of Research Promotion Cell
Cancers of epithelial origin account for the majority of cancer-related deaths. Tight Junctions (TJs) are the principal barrier to paracellular...
Kerry Webinar
News
Biogen and Ionis report positive topline...
ImaginAb announces extension of long-stand...
Press Releases
Saniona Receives U.S. FDA Orphan Drug Designa...
Allarity Therapeutics and Lantern Pharma Enter...
Techno Trends
> A Novel Therapy Discovered for the Treatment of Relapsed or...
> Novel Therapy BXCL501 Developed for the Treatment of Dementia
Projects
> Thermo Fisher Constructs New cGMP Plasmid DNA Manufacturing...
> Fujifilm Invests US$40 million inNew State-of-the-Art Manufacturing...
Events
10 - 12 Aug 2021
CPhI North America
25 - 26 Aug 2021
Innopack Pharma Confex
Research Insights
> Potential synergistic activity of quercetin with antibiotics against...
> A network medicine approach to investigation and population...
> Cell death and biomass reduction in biofilms of multidrug resistant...
  Subscribe  |  e-book Archives  | Advisory Board  
Follow Us Facebook Facebook Facebook
www.pharmafocusasia.com – Owned by Ochre Media Pvt. Ltd.